期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 6, 页码 4565-4577出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c01276
关键词
-
资金
- National Natural Science Foundation of China [81773656]
- National Postdoctoral Foundation of China [2021M693868]
- Key R&D Program of Liaoning Province [2020JH2/10300071]
- Liaoning Province Doctor Startup Fund [2021-BS-133]
By modulating the chirality of the linear dipeptide HS-tLL, the colon-targeting efficiency can be enhanced, providing a potential treatment for inflammatory bowel disease (IBD).
The naturally occurring linear dipeptide JBP923(trans-4-L-Hyp-L-Ser, HS-tLL) with anti-inflammatory effectsshowed potential for the treatment of inflammatory bowel disease(IBD). However, colon-specific delivery after oral administration isstill a challenge because its absorption is mediated by oligopeptidetransporter 1 (PEPT1) in the upper small intestine and because ofits instability in the gastrointestinal tract. Therefore, we aimed toenhance the colon-targeting efficiency by modulating HS-tLL chirality to synthesize eight enantiomers. Among these enantiomers,trans-4-D-Hyp-D-Ser,cis-4-L-Hyp-D-Ser,cis-4-D-Hyp-L-Ser, andcis-4-D-Hyp-D-Ser did not work as substrates of PEPT1 and werestable in the gastrointestinal tract, resulting in enhanced colonic accumulation through the paracellular pathway due to the loosetight junctions in IBD. Interestingly,cis-4-D-Hyp-D-Ser exerted the most potent therapeutic effect on IBD. Ourfindings revealed theimpact of chirality on the colonic accumulation of the linear dipeptide, providing strategies for the colon-targeted delivery of thelinear dipeptide for the treatment of IBD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据